Previous 10 | Next 10 |
home / stock / bsx / bsx articles
Boston Scientific Corporation (NYSE: BSX) has agreed to acquire Axonics Inc (NASDAQ: AXNX) for $71 in cash per share, represent...
Boston Scientific (NYSE:BSX) has outperformed the market over the past 15 years by 2.72% on an annualized basis producing an average annual return ...
Boston Scientific Corporation (NYSE: BSX) said it expects FARAPULSE Pulsed Field Ablation (PFA) System to get FDA approval in the first q...
Boston Scientific (NYSE:BSX) has outperformed the market over the past 10 years by 7.1% on an annualized basis producing an average annual return o...
Boston Scientific (NYSE:BSX) has outperformed the market over the past 10 years by 6.7% on an annualized basis producing an average annual return o...
The third-quarter earnings season has largely been mixed so far, reflecting the impact of the economic uncertainties on profit growth. That said, d...
Wall Street experienced a significant downturn Thursday as volatility surged, triggered by a shift in risk sentiment following a combination of mix...
Boston Scientific Corp (NYSE: BSX) generated Q3 revenues of $3.53 billion, beating the Wall Street estimate of $3.48 billion. The sales increa...
A somber mood looms over Wall Street, stirred by lackluster earnings reports and relentless bond yield increases. Stock futures dipped early Thursd...
News, Short Squeeze, Breakout and More Instantly...
Boston Scientific Corporation Company Name:
BSX Stock Symbol:
NYSE Market:
Boston Scientific Corporation Website:
Shares of Boston Scientific Corporation (NYSE: BSX) traded at a new 52-week high today and are currently trading at $78.31. So far today, approximately 1.5M shares have been exchanged, as compared to an average 30-day volume of 5.37M shares. Boston Scientific Corporation develops, manufacture...
2024-07-08 14:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-02 09:15:03 ET Evercore ISI analyst issues OUTPERFORM recommendation for BSX on July 2, 2024 08:01AM ET. The previous analyst recommendation was Outperform. BSX was trading at $76.41 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...